Replies to post #5581 on InVivo Therapeutics Holdings Corp (NVIVQ)

[BioBull1]

Even at 4 bucks a share, the market cap is simply too high without the market potential of the chronic population. No news is currently bad news.

The company holds roughly a fourth of it's market cap in cash. So this could absolutely go lower...